AUC_Logo_transparent
AUC_Logo_transparent

News

News2026-05-05T15:06:05-04:00

Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction (ED) study

"ED has become more prominent over the last several decades, especially in younger adults, and represents a mounting health concern causing a significant effect on men’s quality of life"

Go to Top